Intellia Therapeutics, Inc. (NTLA)
11.42
+0.08
(+0.71%)
USD |
NASDAQ |
Oct 16, 16:00
11.33
-0.09
(-0.79%)
After-Hours: 20:00
Intellia Therapeutics Cash from Investing (Quarterly) : -141.57M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -141.57M |
| March 31, 2026 | 66.31M |
| December 31, 2025 | 27.53M |
| September 30, 2025 | -0.741M |
| June 30, 2025 | 106.91M |
| March 31, 2025 | 94.33M |
| December 31, 2024 | 151.56M |
| September 30, 2024 | -7.709M |
| June 30, 2024 | -24.19M |
| March 31, 2024 | 5.901M |
| December 31, 2023 | 45.94M |
| September 30, 2023 | 79.50M |
| June 30, 2023 | -34.54M |
| March 31, 2023 | -122.25M |
| December 31, 2022 | -30.15M |
| September 30, 2022 | 47.64M |
| June 30, 2022 | 95.34M |
| March 31, 2022 | 47.47M |
| December 31, 2021 | -159.12M |
| September 30, 2021 | -399.38M |
| June 30, 2021 | 33.26M |
| Date | Value |
|---|---|
| March 31, 2021 | -25.54M |
| December 31, 2020 | -210.92M |
| September 30, 2020 | -153.98M |
| June 30, 2020 | 92.96M |
| March 31, 2020 | 57.45M |
| December 31, 2019 | 27.88M |
| September 30, 2019 | -31.65M |
| June 30, 2019 | 23.25M |
| March 31, 2019 | 5.695M |
| December 31, 2018 | -256.02M |
| September 30, 2018 | -2.016M |
| June 30, 2018 | -0.90M |
| March 31, 2018 | -1.85M |
| December 31, 2017 | -2.397M |
| September 30, 2017 | -2.26M |
| June 30, 2017 | -1.272M |
| March 31, 2017 | -4.162M |
| December 31, 2016 | -3.405M |
| September 30, 2016 | -0.605M |
| June 30, 2016 | -1.147M |
| March 31, 2016 | -1.008M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -10.20M |
| Beam Therapeutics, Inc. | -9.875M |
| Prime Medicine, Inc. | 24.03M |
| 10X Genomics, Inc. | -7.735M |
| Moderna, Inc. | 329.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -83.11M |
| Cash from Financing (Quarterly) | 196.12M |
| Free Cash Flow | -348.69M |
| Free Cash Flow Per Share (Quarterly) | -0.6362 |
| Free Cash Flow to Equity (Quarterly) | -77.84M |
| Free Cash Flow to Firm (Quarterly) | -84.92M |
| Free Cash Flow Yield | -25.55% |